ITI Pharma and Healthcare Fund Regular vs SBI Healthcare Opportunities Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹208 Cr | ₹3416 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 31 Dec 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 32% |
| Expense Ratio | 2.35 | 1.95 |
| Manager | Rohan Korde | Pradeep Kesavan |
| ISIN Code | INF00XX01BL5 | INF200K01446 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Month | -4.47% | -2.13% |
| 6 Month | 11.67% | 14.55% |
| 1 Year | 27.54% | 30.1% |
| 3 Year | 18.15% | 23.13% |
| 5 Year | - | 27.58% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 20.98% | 23.89% |
| 3 Year | 27.81% | 31.58% |
| 5 Year | - | 25.73% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Year | 22.17% | 14.51% |
| 3 Year | 19.97% | 17.07% |
| 5 Year | - | 12.42% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.02% |
| Sharp | - | 1.04% |
| Beta | - | 0.8% |
| Alpha | - | 5.51% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Name | Rohan Korde | Pradeep Kesavan |
| Total AUM | ₹4626 Cr | ₹434274 Cr |
| Fund Manage | 10 | 43 |
| ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.8 | 7.82 |
| Large Cap | 38.11 | 30.06 |
| Mid Cap | 26.43 | 24.84 |
| Small Cap | 33.66 | 37.28 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.8 | 7.82 |
| Pharmaceuticals & Biotechnology | 77 | 57.84 |
| Healthcare Services | 18.01 | 25.46 |
| Chemicals & Petrochemicals | 0.96 | 3.5 |
| Fertilizers & Agrochemicals | 1.03 | - |
| Insurance | 1.2 | - |
| Healthcare Equipment & Supplies | - | 5.38 |
Top Comparisons
ICICI Prudential Equity & Debt Fund - Growth
3Y Returns17.01%
Mirae Asset Aggressive Hybrid Fund -Regular Plan-Growth
3Y Returns10.01%
Invesco India ELSS Tax Saver Fund - Growth
3Y Returns12.18%
Parag Parikh Tax Saver Fund Regular - Growth
3Y Returns15.69%
Edelweiss Government Securities Fund - Regular Plan - Growth Option
3Y Returns6.27%
Axis Gilt Fund - Regular Plan - Growth Option
3Y Returns6.5%
Aditya Birla Sun Life Arbitrage Fund - Regular Plan - Growth
3Y Returns6.26%
Edelweiss Arbitrage Fund- Regular Plan- Growth Option
3Y Returns6.42%